| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |


Departments of Medicine, Genetics, and Pathology, Washington University School of Medicine St. Louis, Missouri 63110
Address requests for reprints to: Dr. Peter Rotwein, Departments of Internal Medicine and Genetics, Washington University, 660 South Euclid Avenue, Box 8127, St. Louis, Missouri 63110.
Abstract
The function of insulin-like growth factors I and II (IGF-I and IGF-II) in embryogenesis is unknown. To investigate the ontogeny of IGF gene expression during mammalian development we used a highly sensitive and specific solutionhybridization assay to determine the steady state levels of IGF mRNAs during midgestation in the rat. IGF-I mRNA can be detected as early as day 11 of embryonic development and rises 8.6-fold over the ensuing 48 h. By contrast IGF-II mRNA is relatively constant over days 11-14 of gestation. These observations suggest that both IGFs may play important roles in early fetal development. (Endocrinology 121: 2141–2144, 1987)
Footnotes
* This work was supported in part by NIH Grants DK-37449 and HD-20805 (to P.R.).
Supported by Medical Scientist Training Program Grant GM-07200.
Recipient of NIH Clinical Investigator Development Award (NS-01018).
Received August 5, 1987.
This article has been cited by other articles:
![]() |
W. Shen, D. Mallon, D. W. Boyle, and E. A. Liechty IGF-I and insulin regulate eIF4F formation by different mechanisms in muscle and liver in the ovine fetus Am J Physiol Endocrinol Metab, September 1, 2002; 283(3): E593 - E603. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Servoss, S. J. Lee, G. Gibney, I. Gozes, D. E. Brenneman, and J. M. Hill IGF-I as a Mediator of VIP/Activity-Dependent Neurotrophic Factor-Stimulated Embryonic Growth Endocrinology, August 1, 2001; 142(8): 3348 - 3353. [Abstract] [Full Text] [PDF] |
||||
![]() |
L Powell-Braxton, P Hollingshead, C Warburton, M Dowd, S Pitts-Meek, D Dalton, N Gillett, and T A Stewart IGF-I is required for normal embryonic growth in mice. Genes & Dev., December 1, 1993; 7(12b): 2609 - 2617. [Abstract] [PDF] |
||||
![]() |
D A Rappolee, K S Sturm, O Behrendtsen, G A Schultz, R A Pedersen, and Z Werb Insulin-like growth factor II acts through an endogenous growth pathway regulated by imprinting in early mouse embryos. Genes & Dev., June 1, 1992; 6(6): 939 - 952. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |